← SynDRA
KRN-633
SynDRA canonical compound SYN0008985 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | FLT1 | FLT4 | KDR |
|---|
| Mechanism of action | VEGFR inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- FLT1 INHIBITOR
- Vascular endothelial growth factor receptor inhibitor
- FLT4 INHIBITOR
- KDR INHIBITOR
- VEGFR inhibitor
Cross-references
Synonyms
- K00589A
- KRN633
- VEGF Receptor Tyrosine Kinase Inhibitor III, KRN633
- KRN633, KRN-633, KRN 633
- N-(2-Chloro-4-((6,7-dimethoxy-4-quinazolinyl)oxy)phenyl)-N′-propylurea
- K00589a
- VEGF receptor tyrosine kinase inhibitor III
- E1V875I8DX
- RefChem:151470
- DTXCID50380384
- MFCD14155620
- C20H21ClN4O4
- UNII-E1V875I8DX
- MLS006011285
- GTPL6057
- orb1301043
- SCHEMBL1249684
- SCHEMBL29356072
- SCHEMBL29375090
- KRN633?
- VPBYZLCHOKSGRX-UHFFFAOYSA-N
- GLXC-05568
- HMS3655O03
- HMS3673M15
- EX-A2087
- BDBM50375642
- FD7289
- s1557
- AKOS025404943
- CCG-268853
- CS-0220
- SB19356
- SDCCGSBI-0086721.P002
- NCGC00346548-01
- NCGC00346548-03
- NCGC00346548-07
- NCGC00346548-09
- NCGC00346548-10
Look up KRN-633 in the interactive SynDRA portal →